Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Preeclampsia and intrauterine growth retardation (IUGR) are serious and frequent pathologies, specific to pregnancy. They represent 70 000 new cases a year, or 9% of pregnancies and cause 50,000 premature births per year in France. The consequences in terms of morbidity and perinatal morbidity and the medical and economic costs make it an issue public health. Pre-eclampsia associates maternal hypertension with dysfunction kidney. There is no cure for pre-eclampsia or IUGR vascular during pregnancy. These pathologies invariably evolve towards a maternal and / or fetal aggravation sometimes very fast. Primary prevention and secondary education and screening for these pathologies are still insufficient. A better understanding of the pathophysiology of these placental vascular pathologies is necessary for the development of supported medical, obstetric and pediatric that will improve the state of health maternal and neonatal
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Vascular group | Pregnant women with vascular pathology |
| |
| Control group |
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| collect of placenta, blood and urinary samples at delivery | Other | collect of placenta, blood and urinary samples at delivery |
|
| Measure | Description | Time Frame |
|---|---|---|
| genomic analysis on placenta | by chromatin immunoprecipitation-sequencing (ChIP-seq) | day of delivery |
| Measure | Description | Time Frame |
|---|---|---|
| genomic analysis on blood | by ChIP-seq | day of delivery |
| genomic analysis on placenta | by immunohistochemistry an polymerase chain-reaction |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Pregnant women
Not provided
pregnant women with or without vascular pathology
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Diane REDEL | Contact | 145175530 | 0033 | diane.redel@chicreteil.fr |
| camille Jung | Contact | 157022268 | 0033 | camille.jung@chicreteil.fr |
| Name | Affiliation | Role |
|---|---|---|
| Edouard Lecarpentier, MD PhD | CHI CRETEIL | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHi Creteil | Recruiting | Créteil | 94000 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011225 | Pre-Eclampsia |
| ID | Term |
|---|---|
| D046110 | Hypertension, Pregnancy-Induced |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D001800 | Blood Specimen Collection |
| ID | Term |
|---|---|
| D013048 | Specimen Handling |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood samples for maternal DNA sequencing and angiogenic factors (VEGF, PLGF, sFLt-1, sQDR) Urinary samples: Angiogenic factors Placenta: for placenta DNA sequencing and angiogenic factors
| day of delivery |
| VEGF blood level | day of delivery |
| PLGF blood level | day of delivery |
| sFlt1 blood level | day of delivery |
| sKDR blood level | day of delivery |
| D011677 | Punctures |
| D013514 | Surgical Procedures, Operative |
| D008919 | Investigative Techniques |